Accessibility Menu
 

Turn Therapeutics

(NASDAQ) TTRX

Current Price$3.35
Market Cap$100.68M
Since IPO (2025)-52%
5 YearN/A
1 YearN/A
1 Month-3%

Turn Therapeutics Financials at a Glance

Market Cap

$100.68M

Revenue (TTM)

$0.00

Net Income (TTM)

$2.87

EPS (TTM)

$0.00

P/E Ratio

-25.53

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$3.35

Volume

442

Open

$3.40

Previous Close

$3.35

Daily Range

$3.26 - $3.40

52-Week Range

$2.57 - $26.50

TTRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Turn Therapeutics

Industry

Pharmaceuticals

Employees

2

CEO

Bradley Burnam

Headquarters

Westlake Village, CA 91362, US

TTRX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-95%

Return on Assets

-26%

Earnings Yield

-3.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.68M

Shares Outstanding

29.79M

Volume

442

Short Interest

0.00%

Avg. Volume

26.11K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$5.86M

EBITDA

$5.81M

Operating Cash Flow

$2.56M

Capital Expenditure

$152.99K

Free Cash Flow

$2.72M

Cash & ST Invst.

$5.08M

Total Debt

$80.38K

Turn Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$100.68M

N/A

Market Cap/Employee

$50.34M

N/A

Employees

2

N/A

Net Income

$1.24M

N/A

EBITDA

$1.37M

N/A

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$5.00M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$34.08K

N/A

Short Term Debt

$46.30K

N/A

Return on Assets

-26.26%

N/A

Return on Invested Capital

-95.13%

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANIXAnixa Biosciences, Inc.
$2.88-4.00%
SEERSeer, Inc.
$2.00+0.50%
CGTXCognition Therapeutics, Inc.
$1.17+4.46%
IKTInhibikase Therapeutics, Inc.
$1.67-7.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$57.40-0.01%
OPENOpendoor Technologies
$5.45+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.87-0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$57.59+0.01%

Questions About TTRX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.